How Secretin Changes Pancreatic Fluid in Healthy People
Part of Digestive system clinical trials.
This study tests how a drug called secretin affects the fluid in your pancreas. It is for healthy people who are already having an endoscopic ultrasound for another reason.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are generally healthy (no serious health problems).
- You are scheduled for an endoscopic ultrasound for a reason not related to your pancreas.
- You are not pregnant or breastfeeding.
- You do not drink more than 2 alcoholic drinks per day and do not smoke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding pancreatic digestive enzymes to tube feeding can improve digestion and outcomes in critically ill adults who have higher risk of not producing enough digestive enzymes. If you qualify, you may receive the enzyme supplement or a comparison treatment while you’re in the ICU.
This trial tests whether pancreatic enzyme supplements can help people with functional dyspepsia, a condition causing ongoing stomach pain or fullness without a clear cause. It is for people who do not have other digestive diseases or H. pylori infection.
This trial tests a new blood test to measure how well your pancreas works. It may help people with chronic pancreatitis understand their condition and quality of life.
This study looks at how blood sugar and certain hormones change in people who have both chronic pancreatitis and diabetes. It aims to understand these patterns better, which might help design future treatments.
This study uses a special pancreas MRI to see how well the pancreas works and how pancreas disease changes over time. It also compares MRI findings in children with different pancreas conditions, including suspected pancreatic insufficiency and episodes of pancreatitis.
This trial studies whether secretin can help the body during “refeeding,” the careful process of restarting nutrition in people hospitalized for restrictive-type anorexia nervosa. It compares participants with very high vs very low urine output during refeeding to see if responses differ.
Hear when a new Exocrine Pancreatic Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.